Merck (MRK) closed at $110.42 in the latest trading session, marking a +1.92% move from the prior day. The stock outperformed ...

Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

It was revealed in a recent SEC filing that Chirfi Guindo, Chief Marketing Officer at Merck & Co (NYSE: MRK) made a ...

Merck & Co shares are trading up 1.19% at $107.25 at the time of this writing on Thursday morning. About Merck & Co. Merck makes pharmaceutical products to treat several condition ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Merck (MRK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth ...

According to TipRanks.com, Haider is a 4-star analyst with an average return of 26.2% and a 87.5% success rate. Haider covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma ...

Shares of Revolution Medicines RVMD slipped 17% yesterday after a Wall Street Journal (WSJ) report said, quoting people familiar with the matter, that pharma bigwig Merck MRK was no longer pursuing ...

The healthcare sector lagged broader equities last year. Novo Nordisk ( NVO 2.86%) and Merck ( MRK 0.62%), two pharmaceutical ...

Merck & Company Inc (NYSE:MRK) has ceased discussions to acquire biotechnology firm Revolution Medicines Inc (NASDAQ:RVMD), following a failure to reach an agreement on the company’s valuation.

Reuters reported that Merck & Co., Inc. (NYSE:MRK)’s MSD unit and the Coalition for Epidemic Preparedness Innovations (CEPI) ...